Prelude Capital Management’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,123
| Closed | -$175K | – | 1412 |
|
|
2024
Q3 | $175K | Sell |
15,123
-7,196
| -32% | -$67.9K | 0.01% | 1086 |
|
|
2024
Q2 | $169K | Buy |
+22,319
| New | +$185K | 0.01% | 1038 |
|
|
2023
Q3 | – | Sell |
-13,439
| Closed | -$191K | – | 1269 |
|
|
2023
Q2 | $191K | Sell |
13,439
-11,862
| -47% | -$167K | 0.01% | 853 |
|
|
2023
Q1 | $377K | Buy |
25,301
+11,834
| +88% | +$179K | 0.02% | 562 |
|
|
2022
Q4 | $200K | Buy |
+13,467
| New | +$220K | 0.01% | 970 |
|
|
2020
Q4 | – | Sell |
-1,433
| Closed | -$23K | – | 1695 |
|
|
2020
Q3 | $23K | Sell |
1,433
-2,382
| -62% | -$44.3K | ﹤0.01% | 1305 |
|
|
2020
Q2 | $65K | Buy |
+3,815
| New | +$56.6K | ﹤0.01% | 1084 |
|
|
2019
Q2 | – | Sell |
-4,000
| Closed | -$109K | – | 1947 |
|
|
2019
Q1 | $109K | Buy |
+4,000
| New | +$134K | 0.01% | 902 |
|
|
2018
Q3 | – | Sell |
-1,528
| Closed | -$66K | – | 1915 |
|
|
2018
Q2 | $66K | Hold |
1,528
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q1 | $85K | Buy |
+1,528
| New | +$83.8K | 0.01% | 920 |
|
|
2017
Q2 | – | Sell |
-1,178
| Closed | -$82K | – | 1747 |
|
|
2017
Q1 | $82K | Sell |
1,178
-344
| -23% | -$23.9K | 0.01% | 851 |
|
|
2016
Q4 | $101K | Buy |
+1,522
| New | +$99K | 0.01% | 827 |
|
|
2016
Q3 | – | Sell |
-240
| Closed | -$17K | – | 1721 |
|
|
2016
Q2 | $17K | Sell |
240
-709
| -75% | -$48.7K | ﹤0.01% | 1321 |
|
|
2016
Q1 | $61K | Buy |
+949
| New | +$63K | 0.01% | 925 |
|
|
2015
Q4 | – | Sell |
-1,102
| Closed | -$85K | – | 1588 |
|
|
2015
Q3 | $85K | Buy |
1,102
+306
| +38% | +$24.7K | 0.01% | 893 |
|
|
2015
Q2 | $59K | Sell |
796
-792
| -50% | -$57K | 0.01% | 1099 |
|
|
2015
Q1 | $115K | Buy |
1,588
+248
| +19% | +$17.2K | 0.02% | 946 |
|
|
2014
Q4 | $89K | Sell |
1,340
-1,611
| -55% | -$98.3K | 0.01% | 1049 |
|
|
2014
Q3 | $162K | Buy |
2,951
+2,275
| +337% | +$129K | 0.02% | 802 |
|
|
2014
Q2 | $39K | Sell |
676
-938
| -58% | -$55.2K | 0.01% | 1484 |
|
|
2014
Q1 | $100K | Buy |
1,614
+854
| +112% | +$49.7K | 0.01% | 1016 |
|
|
2013
Q4 | $41K | Buy |
760
+160
| +27% | +$8.59K | 0.01% | 1089 |
|
|
2013
Q3 | $30K | Buy |
+600
| New | +$29.3K | ﹤0.01% | 1129 |
|
Other funds holding MD
RCMNY
Prelude Capital Management's MD Position: Q4 2024 in Review
Prelude Capital Management sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 15,123 shares — an estimated $175K sold.
Prelude Capital Management first reported a position in MD in Q3 2013 and held it in 23 quarters. The position peaked at $377K in Q1 2023. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.
- Prelude Capital Management reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
- Prelude Capital Management sold 15,123 Pediatrix Medical shares in Q4 2024, an estimated $175K.
- Prelude Capital Management first reported a position in Pediatrix Medical in Q3 2013 and held it in 23 quarters.
- Prelude Capital Management's Pediatrix Medical position peaked at $377K in Q1 2023.
- 229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.
Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.